MUSECHEM: LEADING PROVIDER OF PEPTIDE CHEMICALS AND MORE

The MAPK/ERK signaling pathway is one more essential target for inhibitors. This pathway is included in managing cell growth, survival, and differentiation. Inhibitors targeting MAPK/ERK are employed in cancer treatments to stop unchecked cell expansion and tumor development. JAK/STAT signaling inhibitors regulate immune feedbacks and are utilized